Attributes | Values |
---|
rdf:type
| |
Description
| - Byl syntetizován pasivně směrovaný systém pro dopravu léčiv založený na vodorozpustných kopolymerech N-(2-hydroxypropyl)methakrylamidu obsahujících léčivo doxorubicin a nebo gemcitabin navázané přes biodegradovatelnou spojku pro kombinovanou radioterapii a chemoterapii nádorových onemocnění. Účinnost kombinované radio a chemoterapie byla testována na radio a chemoresistantním Dunning AT1 krysím karcinomu prostaty. (cs)
- A passively targeted water-soluble polymer drug delivery system based on N-(2-hydroxypropyl)methacrylamide copolymers bearing doxorubicin and/or gemcitabine was designed for combined cancer therapy, taking advantage of both radiotherapeutical and chemotherapeutical effects of the drugs attached to the polymer carrier via biodegradable spacers. The syngeneic and radio- and chemoresistant Dunning AT1 rat prostate carcinoma was used as a tumour model
- A passively targeted water-soluble polymer drug delivery system based on N-(2-hydroxypropyl)methacrylamide copolymers bearing doxorubicin and/or gemcitabine was designed for combined cancer therapy, taking advantage of both radiotherapeutical and chemotherapeutical effects of the drugs attached to the polymer carrier via biodegradable spacers. The syngeneic and radio- and chemoresistant Dunning AT1 rat prostate carcinoma was used as a tumour model (en)
|
Title
| - Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy
- Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy (en)
- Pasivně směrovaná polymerní nanoléčiva pro radiochemoterapii nádorových onemocnění (cs)
|
skos:prefLabel
| - Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy
- Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy (en)
- Pasivně směrovaná polymerní nanoléčiva pro radiochemoterapii nádorových onemocnění (cs)
|
skos:notation
| - RIV/61389013:_____/08:00312213!RIV09-AV0-61389013
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| - P(1M0505), Z(AV0Z40500505)
|
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/61389013:_____/08:00312213
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - tumors; polymeric drugs; chemotherapy (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - GB - Spojené království Velké Británie a Severního Irska
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - British Journal of Cancer
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Ulbrich, Karel
- Šubr, Vladimír
- Lammers, T.
- Kiessling, F.
- Storm, G.
- Heilmann, M.
- Peschke, P.
- Hennink, W.
- Huber, P.
- Debus, J.
- Kühnlein, R.
|
http://linked.open...ain/vavai/riv/wos
| |
http://linked.open...n/vavai/riv/zamer
| |
issn
| |
number of pages
| |